- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04333199
Timely Nudge About Lab Results to Increase myGeisinger Uptake
Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.
The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.
The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Pennsylvania
-
Danville, Pennsylvania, Förenta staterna, 17822
- Geisinger
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Geisinger patient for whom a lab was ordered within 30 days prior to email date
- Patient's lab test result released day before email date
Exclusion Criteria:
- Patient already enrolled in myGeisinger
- Patient has already declined myGeisinger
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Control
Patients do not receive an email
|
|
|
Experimentell: Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
|
Email
Email
|
|
Experimentell: Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
|
Email
Email
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Tidsram: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
Tidsram: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
|
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
Tidsram: 1 week post-intervention
|
Email was opened (yes / no)
|
1 week post-intervention
|
|
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
Tidsram: 1 week post-intervention
|
Link / button to start the enrollment process was clicked (yes / no)
|
1 week post-intervention
|
|
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
Tidsram: 1 month post-intervention
|
Patient unsubscribed from these email communications (yes / no)
|
1 month post-intervention
|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Tidsram: 1 month post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 month post-intervention
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- 2020-0316
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- ANALYTIC_CODE
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .